Skip to main content
Top
Published in: European Journal of Epidemiology 2/2017

Open Access 01-02-2017 | PERINATAL EPIDEMIOLOGY

Human chorionic gonadotropin (hCG) concentrations during the late first trimester are associated with fetal growth in a fetal sex-specific manner

Authors: Mirjana Barjaktarovic, Tim I. M. Korevaar, Vincent W. V. Jaddoe, Yolanda B. de Rijke, Theo J. Visser, Robin P. Peeters, Eric A. P. Steegers

Published in: European Journal of Epidemiology | Issue 2/2017

Login to get access

Abstract

Human chorionic gonadotropin (hCG) is a pregnancy-specific hormone that regulates placental development. hCG concentrations vary widely throughout gestation and differ based on fetal sex. Abnormal hCG concentrations are associated with adverse pregnancy outcomes including fetal growth restriction. We studied the association of hCG concentrations with fetal growth and birth weight. In addition, we investigated effect modification by gestational age of hCG measurement and fetal sex. Total serum hCG (median 14.4 weeks, 95 % range 10.1–26.2), estimated fetal weight (measured by ultrasound during 18–25th weeks and >25th weeks) and birth weight were measured in 7987 mother–child pairs from the Generation R cohort and used to establish fetal growth. Small for gestational age (SGA) was defined as a standardized birth weight lower than the 10th percentile of the study population. There was a non-linear association of hCG with birth weight (P = 0.009). However, only low hCG concentrations measured during the late first trimester (11th and 12th week) were associated with birth weight and SGA. Low hCG concentrations measured in the late first trimester were also associated with decreased fetal growth (P = 0.0002). This was the case for both male and female fetuses. In contrast, high hCG concentrations during the late first trimester were associated with increased fetal growth amongst female, but not male fetuses. Low hCG in the late first trimester is associated with lower birth weight due to a decrease in fetal growth. Fetal sex differences exist in the association of hCG concentrations with fetal growth.
Appendix
Available only for authorised users
Literature
1.
go back to reference Barker DJ, Lampl M, Roseboom T, Winder N. Resource allocation in utero and health in later life. Placenta. 2012;33(Suppl 2):e30–4.CrossRefPubMed Barker DJ, Lampl M, Roseboom T, Winder N. Resource allocation in utero and health in later life. Placenta. 2012;33(Suppl 2):e30–4.CrossRefPubMed
2.
go back to reference Salafia CM, Zhang J, Charles AK, et al. Placental characteristics and birthweight. Paediatr Perinat Epidemiol. 2008;22(3):229–39.CrossRefPubMed Salafia CM, Zhang J, Charles AK, et al. Placental characteristics and birthweight. Paediatr Perinat Epidemiol. 2008;22(3):229–39.CrossRefPubMed
4.
go back to reference Albu AR, Anca AF, Horhoianu VV, Horhoianu IA. Predictive factors for intrauterine growth restriction. J Med Life. 2014;7(2):165–71.PubMedPubMedCentral Albu AR, Anca AF, Horhoianu VV, Horhoianu IA. Predictive factors for intrauterine growth restriction. J Med Life. 2014;7(2):165–71.PubMedPubMedCentral
5.
go back to reference Eriksson JG. Early programming of later health and disease: factors acting during prenatal life might have lifelong consequences. Diabetes. 2010;59(10):2349–50.CrossRefPubMedPubMedCentral Eriksson JG. Early programming of later health and disease: factors acting during prenatal life might have lifelong consequences. Diabetes. 2010;59(10):2349–50.CrossRefPubMedPubMedCentral
6.
go back to reference Barker DJ. Adult consequences of fetal growth restriction. Clin Obstet Gynecol. 2006;49(2):270–83.CrossRefPubMed Barker DJ. Adult consequences of fetal growth restriction. Clin Obstet Gynecol. 2006;49(2):270–83.CrossRefPubMed
9.
go back to reference Brouillet S, Hoffmann P, Feige JJ, Alfaidy N. EG-VEGF: a key endocrine factor in placental development. Trends Endocrinol Metab. 2012;23(10):501–8.CrossRefPubMed Brouillet S, Hoffmann P, Feige JJ, Alfaidy N. EG-VEGF: a key endocrine factor in placental development. Trends Endocrinol Metab. 2012;23(10):501–8.CrossRefPubMed
10.
go back to reference Tsampalas M, Gridelet V, Berndt S, Foidart JM, Geenen V, Perrier d’Hauterive S. Human chorionic gonadotropin: a hormone with immunological and angiogenic properties. J Reprod Immunol. 2010;85(1):93–8.CrossRefPubMed Tsampalas M, Gridelet V, Berndt S, Foidart JM, Geenen V, Perrier d’Hauterive S. Human chorionic gonadotropin: a hormone with immunological and angiogenic properties. J Reprod Immunol. 2010;85(1):93–8.CrossRefPubMed
11.
go back to reference Pidoux G, Gerbaud P, Cocquebert M, et al. Review: human trophoblast fusion and differentiation: lessons from trisomy 21 placenta. Placenta. 2012;33(Suppl):S81–6.CrossRefPubMed Pidoux G, Gerbaud P, Cocquebert M, et al. Review: human trophoblast fusion and differentiation: lessons from trisomy 21 placenta. Placenta. 2012;33(Suppl):S81–6.CrossRefPubMed
12.
go back to reference Reshef E, Lei ZM, Rao CV, Pridham DD, Chegini N, Luborsky JL. The presence of gonadotropin receptors in nonpregnant human uterus, human placenta, fetal membranes, and decidua. J Clin Endocrinol Metab. 1990;70(2):421–30.CrossRefPubMed Reshef E, Lei ZM, Rao CV, Pridham DD, Chegini N, Luborsky JL. The presence of gonadotropin receptors in nonpregnant human uterus, human placenta, fetal membranes, and decidua. J Clin Endocrinol Metab. 1990;70(2):421–30.CrossRefPubMed
13.
go back to reference Goetzl L, Krantz D, Simpson JL, et al. Pregnancy-associated plasma protein A, free beta-hCG, nuchal translucency, and risk of pregnancy loss. Obstet Gynecol. 2004;104(1):30–6.CrossRefPubMed Goetzl L, Krantz D, Simpson JL, et al. Pregnancy-associated plasma protein A, free beta-hCG, nuchal translucency, and risk of pregnancy loss. Obstet Gynecol. 2004;104(1):30–6.CrossRefPubMed
14.
go back to reference Keikkala E, Vuorela P, Laivuori H, Romppanen J, Heinonen S, Stenman UH. First trimester hyperglycosylated human chorionic gonadotrophin in serum—a marker of early-onset preeclampsia. Placenta. 2013;34(11):1059–65.CrossRefPubMed Keikkala E, Vuorela P, Laivuori H, Romppanen J, Heinonen S, Stenman UH. First trimester hyperglycosylated human chorionic gonadotrophin in serum—a marker of early-onset preeclampsia. Placenta. 2013;34(11):1059–65.CrossRefPubMed
15.
go back to reference Rabie NZ, Magann EF. Human chronic gonadotropin concentrations in very early pregnancy and subsequent preeclampsia. Womens Health (Lond Engl). 2014;10(5):483–5.CrossRef Rabie NZ, Magann EF. Human chronic gonadotropin concentrations in very early pregnancy and subsequent preeclampsia. Womens Health (Lond Engl). 2014;10(5):483–5.CrossRef
16.
go back to reference Androutsopoulos G, Gkogkos P, Decavalas G. Mid-trimester maternal serum HCG and alpha fetal protein levels: clinical significance and prediction of adverse pregnancy outcome. Int J Endocrinol Metab. 2013;11(2):102–6.CrossRefPubMedPubMedCentral Androutsopoulos G, Gkogkos P, Decavalas G. Mid-trimester maternal serum HCG and alpha fetal protein levels: clinical significance and prediction of adverse pregnancy outcome. Int J Endocrinol Metab. 2013;11(2):102–6.CrossRefPubMedPubMedCentral
17.
go back to reference Gonen R, Perez R, David M, Dar H, Merksamer R, Sharf M. The association between unexplained second-trimester maternal serum hCG elevation and pregnancy complications. Obstet Gynecol. 1992;80(1):83–6.PubMed Gonen R, Perez R, David M, Dar H, Merksamer R, Sharf M. The association between unexplained second-trimester maternal serum hCG elevation and pregnancy complications. Obstet Gynecol. 1992;80(1):83–6.PubMed
18.
go back to reference Jaddoe VW, van Duijn CM, Franco OH, et al. The Generation R Study: design and cohort update 2012. Eur J Epidemiol. 2012;27(9):739–56.CrossRefPubMed Jaddoe VW, van Duijn CM, Franco OH, et al. The Generation R Study: design and cohort update 2012. Eur J Epidemiol. 2012;27(9):739–56.CrossRefPubMed
19.
go back to reference Korevaar TI, Steegers EA, de Rijke YB, et al. Reference ranges and determinants of total hCG levels during pregnancy: the Generation R Study. Eur J Epidemiol. 2015;30(9):1057–66.CrossRefPubMedPubMedCentral Korevaar TI, Steegers EA, de Rijke YB, et al. Reference ranges and determinants of total hCG levels during pregnancy: the Generation R Study. Eur J Epidemiol. 2015;30(9):1057–66.CrossRefPubMedPubMedCentral
20.
go back to reference Verburg BO, Steegers EA, De Ridder M, et al. New charts for ultrasound dating of pregnancy and assessment of fetal growth: longitudinal data from a population-based cohort study. Ultrasound Obstet Gynecol. 2008;31(4):388–96.CrossRefPubMed Verburg BO, Steegers EA, De Ridder M, et al. New charts for ultrasound dating of pregnancy and assessment of fetal growth: longitudinal data from a population-based cohort study. Ultrasound Obstet Gynecol. 2008;31(4):388–96.CrossRefPubMed
21.
22.
go back to reference Medici M, de Rijke YB, Peeters RP, et al. Maternal early pregnancy and newborn thyroid hormone parameters: the Generation R study. J Clin Endocrinol Metab. 2012;97(2):646–52.CrossRefPubMed Medici M, de Rijke YB, Peeters RP, et al. Maternal early pregnancy and newborn thyroid hormone parameters: the Generation R study. J Clin Endocrinol Metab. 2012;97(2):646–52.CrossRefPubMed
23.
go back to reference Goldstein H. Multilevel statistical models. Hoboken: John Wiley & Sons; 2011. Goldstein H. Multilevel statistical models. Hoboken: John Wiley & Sons; 2011.
24.
go back to reference Niemeijer MN, Grooten IJ, Vos N, et al. Diagnostic markers for hyperemesis gravidarum: a systematic review and metaanalysis. Am J Obstet Gynecol. 2014;211(2):1–15.CrossRef Niemeijer MN, Grooten IJ, Vos N, et al. Diagnostic markers for hyperemesis gravidarum: a systematic review and metaanalysis. Am J Obstet Gynecol. 2014;211(2):1–15.CrossRef
25.
go back to reference Sterne JA, White IR, Carlin JB, et al. Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ. 2009;338:b2393.CrossRefPubMedPubMedCentral Sterne JA, White IR, Carlin JB, et al. Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ. 2009;338:b2393.CrossRefPubMedPubMedCentral
26.
go back to reference Thomas CM, Reijnders FJ, Segers MF, Doesburg WH, Rolland R. Human choriogonadotropin (hCG): comparisons between determinations of intact hCG, free hCG beta-subunit, and “total” hCG + beta in serum during the first half of high-risk pregnancy. Clin Chem. 1990;36(4):651–5.PubMed Thomas CM, Reijnders FJ, Segers MF, Doesburg WH, Rolland R. Human choriogonadotropin (hCG): comparisons between determinations of intact hCG, free hCG beta-subunit, and “total” hCG + beta in serum during the first half of high-risk pregnancy. Clin Chem. 1990;36(4):651–5.PubMed
27.
go back to reference Kirkegaard I, Henriksen TB, Uldbjerg N. Early fetal growth, PAPP-A and free beta-hCG in relation to risk of delivering a small-for-gestational age infant. Ultrasound Obstet Gynecol. 2011;37(3):341–7.CrossRefPubMed Kirkegaard I, Henriksen TB, Uldbjerg N. Early fetal growth, PAPP-A and free beta-hCG in relation to risk of delivering a small-for-gestational age infant. Ultrasound Obstet Gynecol. 2011;37(3):341–7.CrossRefPubMed
28.
go back to reference Krantz D, Goetzl L, Simpson JL, et al. Association of extreme first-trimester free human chorionic gonadotropin-beta, pregnancy-associated plasma protein A, and nuchal translucency with intrauterine growth restriction and other adverse pregnancy outcomes. Am J Obstet Gynecol. 2004;191(4):1452–8.CrossRefPubMed Krantz D, Goetzl L, Simpson JL, et al. Association of extreme first-trimester free human chorionic gonadotropin-beta, pregnancy-associated plasma protein A, and nuchal translucency with intrauterine growth restriction and other adverse pregnancy outcomes. Am J Obstet Gynecol. 2004;191(4):1452–8.CrossRefPubMed
29.
go back to reference Abdel Moety GA, Almohamady M, Sherif NA, et al. Could first-trimester assessment of placental functions predict preeclampsia and intrauterine growth restriction? A prospective cohort study. J Matern Fetal Neonatal Med. 2016;29(3):1–5.CrossRef Abdel Moety GA, Almohamady M, Sherif NA, et al. Could first-trimester assessment of placental functions predict preeclampsia and intrauterine growth restriction? A prospective cohort study. J Matern Fetal Neonatal Med. 2016;29(3):1–5.CrossRef
30.
31.
go back to reference Burton GJ. Oxygen, the Janus gas; its effects on human placental development and function. J Anat. 2009;215(1):27–35.CrossRefPubMed Burton GJ. Oxygen, the Janus gas; its effects on human placental development and function. J Anat. 2009;215(1):27–35.CrossRefPubMed
32.
go back to reference Gol M, Altunyurt S, Cimrin D, Guclu S, Bagci M, Demir N. Different maternal serum hCG levels in pregnant women with female and male fetuses: does fetal hypophyseal–adrenal–gonadal axis play a role? J Perinat Med. 2004;32(4):342–5.CrossRefPubMed Gol M, Altunyurt S, Cimrin D, Guclu S, Bagci M, Demir N. Different maternal serum hCG levels in pregnant women with female and male fetuses: does fetal hypophyseal–adrenal–gonadal axis play a role? J Perinat Med. 2004;32(4):342–5.CrossRefPubMed
33.
go back to reference Yaron Y, Lehavi O, Orr-Urtreger A, et al. Maternal serum HCG is higher in the presence of a female fetus as early as week 3 post-fertilization. Hum Reprod. 2002;17(2):485–9.CrossRefPubMed Yaron Y, Lehavi O, Orr-Urtreger A, et al. Maternal serum HCG is higher in the presence of a female fetus as early as week 3 post-fertilization. Hum Reprod. 2002;17(2):485–9.CrossRefPubMed
34.
go back to reference Schwarzler P, Bland JM, Holden D, Campbell S, Ville Y. Sex-specific antenatal reference growth charts for uncomplicated singleton pregnancies at 15–40 weeks of gestation. Ultrasound Obstet Gynecol. 2004;23(1):23–9.CrossRefPubMed Schwarzler P, Bland JM, Holden D, Campbell S, Ville Y. Sex-specific antenatal reference growth charts for uncomplicated singleton pregnancies at 15–40 weeks of gestation. Ultrasound Obstet Gynecol. 2004;23(1):23–9.CrossRefPubMed
35.
Metadata
Title
Human chorionic gonadotropin (hCG) concentrations during the late first trimester are associated with fetal growth in a fetal sex-specific manner
Authors
Mirjana Barjaktarovic
Tim I. M. Korevaar
Vincent W. V. Jaddoe
Yolanda B. de Rijke
Theo J. Visser
Robin P. Peeters
Eric A. P. Steegers
Publication date
01-02-2017
Publisher
Springer Netherlands
Published in
European Journal of Epidemiology / Issue 2/2017
Print ISSN: 0393-2990
Electronic ISSN: 1573-7284
DOI
https://doi.org/10.1007/s10654-016-0201-3

Other articles of this Issue 2/2017

European Journal of Epidemiology 2/2017 Go to the issue